Ups and downs for Nobel Bourse

A virtual stock market for trading on Nobel Prize candidates missed medicine winners altogether

Written byNed Stafford
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Champagne corks might have been popping last night in New York and Seattle, home base for the winners of the 2004 Nobel Prize in Physiology or Medicine, but there were no celebrations for the German team who run the Nobel Prize Bourse, an Internet-based virtual stock market designed to predict prize winners.

Around midday on Monday (October 4) in Europe, Richard Axel, of the Howard Hughes Medical Institute and Columbia University in New York, and Linda B. Buck, of the Fred Hutchinson Cancer Research Center in Seattle, were named winners of the 2004 Nobel Prize in Medicine for their work on olfactory reception.

But Axel and Buck had not been suggested as possible winners by any of the participants of the Nobel Prize Bourse, according to Christoph Kepper, an e-commerce doctoral student at Johann Wolfgang Goethe University in Frankfurt, who manages technical aspects of the Bourse's Web site.

"It's disappointing. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform